investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
VADIS TRIAL: PHASE II TRIAL OF E75 PEPTIDE VACCINE IN WOMEN WITH DCIS OF THE BREAST
Powel Brown
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Powel Brown
University of Texas MD Anderson Cancer Center
Houston, United States
Related projects
Amato J Giaccia
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
Breast
Radiation Oncology
Suzanne A Fuqua
Integration of Predictive Biomarkers of Hormone Resistance in Breast Cancer
Breast
Laura Alice Stransky
Elucidating the mechanism of mTORC1 activation by amino acids
Breast
Pathology
Mark Lewandoski
The Role of Fgf Signaling in Vertebrate DevelopmentĀ
Breast
Sandra Mcallister
Understanding How Breast Cancers Activate and Respond to the Systemic Environment
Breast
Brian S Schaffhausen
Products of the Transforming Genes of Polyomavirus
Breast
Pathology
Fraser Symmans
Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer
Breast
Powel Brown
A MULTICENTER PHASE II STUDY OF DOCOSAHEXAENOIC ACID IN PATIENTS WITH A HISTORY OF BREAST CANCER, PREMALIGNANT LESIONS, OR BENIGN BREAST DISEASE
Breast
Valen Earl Johnson
Consistent Model Selection in the p>>n Setting
Breast